Select Committee on Defence Minutes of Evidence


Examination of Witnesses (Questions 120-139)

DR LEWIS MOONIE MP, MR COLIN BALMER AND MR MARTIN EARWICKER

TUESDAY 21 JANUARY 2003

  120. No, Minister, let me finish and then you may respond.
  (Dr Moonie) I certainly shall.

  121.—In which the Minute could be protested against, if you like, and that included the days of the Christmas recess. I think it is unfortunate that we were not given more time.
  (Dr Moonie) I am sorry, that is not the case. You are allowed 14 sitting days in which to lodge an objection. By lodging it on 17 December rather than on 8 January when we came back I actually gave you nearly three weeks extra time in which to decide whether to do something. I could have lodged that on the day we returned and the closing date for objections would have been exactly the same as it was.

  122. That is not what the Table Office told me.
  (Dr Moonie) I am sorry, the Table Office is wrong.

  123. The Table Office runs the House of Commons but I accept what an official of the House of Commons—
  (Dr Moonie) It is 14 sitting days. That is what the regulation says, so you had two to three weeks extra in which to lodge any objections, so did Llew Smith.

  124. In the meantime Mr Balmer has very helpfully come up with the figures I need.
  (Dr Moonie) I had them as well but, as you say—
  (Mr Balmer) If we look at all the cost elements over the whole period of the process which began, as you will recall, after the Strategic Defence Review of 1998, it will be of the order of £80 million.

Chairman

  125. £80 million; is that for DERA as well?
  (Mr Balmer) That is a mixture of the MoD's own costs which is about £19 million, primarily for advisers, financial, legal, and others. In the DERA annual report for 2001 there is a total of about £39 million, primarily for the separation as between QinetiQ and the DSTL for the separation of IT systems geographically and the separation of facilities and the records audit separation process. QinetiQ have since incurred in their annual report of 2002 about another £14 million with another £4 million or so still to come. DSTL have incurred about £3.3 million, again as part of the separation process, the total of which comes to over £80 million.

  126. Can we accept that as a definitive figure or would you like to drop us a note?
  (Mr Balmer) No, those ought to be the final figures, there ought not be any further figures because we are so close to completion.

  Chairman: Thank you. Rachel?

Rachel Squire

  127. Can I ask the Minister and indeed Mr Balmer, given what you have just said, and given that I am an MP with a constituency interest as I cover the area of Rosyth which includes QinetiQ, whether you think the money that has been spent on this further reorganisation of facilities, which to my knowledge over the last ten years have had successive reorganisations, could have been better spent directly on research and technology rather than on this constant reorganisation which is very complex and is still going on?
  (Dr Moonie) What I can say is that we decided to embark on this route. I am well aware that many members of the Committee disagreed with the MoD—

Chairman

  128. Not just many members, Minister, every member.
  (Dr Moonie) Alright, I was looking for some port in a storm—every member. I do not share that view. I think that this was something that had to be done. I think the way in which the pattern of research is changing meant that this company had to go out and try to make its fortune, therefore, these costs were inevitable. It does point to the fact there are at least some parts of the industry doing rather well just now, those who advise on privatisation.

Rachel Squire

  129. Indeed. Can I also just clarify, coming back to the issue of pensions and so on, if people have decided not to transfer their pension, presumably they just started as new members of whatever is the new scheme or are they continuing to pay into the previous MoD pension scheme?
  (Mr Balmer) People were not allowed to stay in the Civil Service scheme, they had to leave that scheme. The choice they had was whether they transferred their service into the new scheme or whether they froze the Civil Service pension and started a new one in the company scheme.

  130. Can I follow that up by asking if the MoD take decisions which affect the QinetiQ site and its testing facilities and which then lead to, frankly, jobs being surplus, to put it politely, will the MoD cover the cost of any early retirement or redundancy or will that be covered by QinetiQ?
  (Mr Balmer) In the first instance, it obviously falls to QinetiQ because all rationalisation costs are for them, whether it is rebuilding, sale costs or redundancy costs. Where the costs eventually fall will depend upon the fine detail of the contract that is still being negotiated to put in place this long-term partnering arrangement.

  131. So there is still the possibility that where effects on this site are the direct result of MoD decisions it is still being negotiated as to who will bear the costs in respect to personnel?
  (Mr Balmer) What we are looking to put in place is a normal commercial arrangement and as with a normal commercial arrangement with any company if the MoD changes an order, or decides not to place an order the impact on the company will vary and the company will expect to pick up its own costs. Quite often in relation to defence expenditure some of those costs will inevitably find their way back to the MoD because we sustain quite a lot of the overheads of the relevant companies so some costs will automatically find their way back into our budget.

  132. Moving on then from all of these costs, when do you expect Qinetiq's financial performance to step up a gear as a result of Carlyle's input?
  (Dr Moonie) You are asking us to predict the future, which is not an easy thing to do.

Mr Roy

  133. Go on!
  (Dr Moonie) We expect to see the effects fairly quickly and I certainly hope to see a growth in value substantially over the next few years.

Rachel Squire

  134. Can I then follow it up by saying that QinetiQ already has site rationalisation plans in train along with a new 25-year test and evaluation partnering arrangement to bring £300 million of savings in that area. As Carlyle will soon own a third of QinetiQ, will they be able to reap a similar share in the benefit of those measures which have been introduced, frankly without Carlyle's help?
  (Mr Balmer) Carlyle owns a third of the equity so to the extent that the value of the company grows then Carlyle will receive a third of it.

  135. Okay. Can I finally then ask that as Carlyle's experience has been mainly in non-defence areas, is there not a risk for the MoD that technologies of particular relevance in the defence field will not be pursued as fully as they might and will not be seen as financially attractive, particularly in the short term, as other areas?
  (Dr Moonie) I think that QinetiQ are quite able to stand on their own two feet where the evaluation of technology and its exploitation is concerned. What we were seeking with a partner through Carlyle is somebody who would be complementary to QinetiQ's undoubted skills in technological development and research, and I think that that is what we have got. If the company is going to be successful in the market place you need marketing skills, commercial skills and financial skills, and these are things that Carlyle will bring to the table.

Syd Rapson

  136. Carlyle's time horizon is likely to be shorter than the MoD's, they are venture capitalists after all, and you have indicated that QinetiQ will be floated in two or three years' time. How will you ensure that the strategic direction of QinetiQ fosters the long-term as well as the short-term well-being?
  (Dr Moonie) There are two things there. I think it is actually six years.
  (Mr Balmer) We have said three to five years.
  (Dr Moonie) It will depend on how quickly the company grows in value, what people think of it. Carlyle's record tends to show that as good venture capitalists they are interested in capital growth and I think that is very important. Had QinetiQ gone for a disastrous total share placement and had the company been sold on the open market then they would have been at the prey of funds, most of whose views do not look beyond the next quarter's balance in terms of profits being distributed. Carlyle is not like that and I think they do have a stake in seeing the company grow. They are prepared to wait and take their money out as an increase in the notional value and we will gain by that as well.

  137. You have got no concerns at all that the remuneration packages for the senior managers at QinetiQ will encourage them to strive to maximise the company's returns over the next three or four years at the expense of its longer-term viability to make the company look that much better?
  (Dr Moonie) I spent a great deal of time with my financial and other people on working out this package. I wanted to ensure that every employee got at least some small chance to benefit from it and at the same time, shall we say, that there were not the chances to make totally unwarranted major gains without producing major growth. If you look at the package as we have constructed it there is a potential for substantial earnings from the top. The company has to treble or quadruple in value in order to do that. If that happens then, of course, our stake in the company will grow commensurately and I think we will deserve that reward. It may still seem very high to some people but I think it is very reasonable and a good challenge to them to grow the company.
  (Mr Balmer) I think it is worth making the point in relation to senior management remuneration that, yes, we are looking for the company to grow several times if that can be achieved. That growth will be measured at the point that we sell it. The market place will not buy a company at that value unless it has got a long-term future. We are not looking for either Carlyle or the MoD to be extracting value in the short-term. We are looking for the value of the company to grow and that value will be assessed by people who would be buying the shares from us who would expect them to continue to be of value in the future.

  138. Can I just go back a little bit. I was asking about the remuneration package of the senior managers at QinetiQ and you said that you were involved heavily in the construction of those packages. From earlier evidence we were told that the MoD sat in the room and listened and never said anything when the packages were being discussed. I assume that your version is right?
  (Dr Moonie) I do not care what the rest of the MoD did, what counted was my view of it and since that was one of the things I had been specifically asked to look at I can assure that I was extremely voluble when we discussed it and when I finally gave my approval to it. I can give you that cast iron guarantee.
  (Mr Balmer) As one of the people who have been sitting in various rooms can I just describe what the process has been. Salaries and bonuses have been very much for the company's remuneration committee to determine based on the pressures that apply to senior managers in the private marketplace. The MoD observers on the board, of which I have been one, have been content to allow the board to make those judgments very much themselves. When it came to the incentive proposals for share options the company was the first to draw up the proposals but they then gave those proposals to us, we took them away and we sat in rooms ourselves with our own advisers and we advised ministers on what the scheme should be.

  139. Can I ask about the flotation. What sort of factors will help you judge in due course when the time is right for the floatation of QinetiQ on the stock market?
  (Dr Moonie) Basically there are two things and one is contingent on the other: the degree of success that QinetiQ have in their growing of business, which will largely be done through the commercial side, and the amount of money we are likely to get back from it. We are just human. When we do come and sell our stake in it we do want to make a good return, it is only natural. It is a combination of these two. We want the company to be a success and we want them to feel it is the right time for them to make the break. We are not just going to do it for the sake of doing it.


 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2003
Prepared 9 April 2003